Assessment of comorbidities and associated factors among breast cancer patients at Tikur Anbesa Hospital, Ethiopia, 2017
No Thumbnail Available
Date
2018-09
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa Universty
Abstract
Back ground: Breast cancer is the most common cancer in women worldwide. Approximately 1.7 million new cases were recorded globally in 2012, accounting for 25 percent of all new cases of cancer in women. Because of an increased vulnerability to breast cancer there is increasing comorbid conditions at the time of diagnosis. Comorbidity is an illness other than the principal diagnosis that influences the outcome of treatment. The number of comorbidities per individual patient ranged from none to 13.
Objective: To assess comorbidities and associated factors among breast cancer patients who have been treated and made follow up in Tikur Anbesa Hospital, Addis Ababa, Ethiopia
Methods: A facility based cross-sectional study design was employed among a total of 404 randomly selected breast cancer patients who had follow up in Tikur Anbesa Referral Hospital. Every other patient who came for follows ups were interviewed and their charts were tracked and reviewed to assess comorbidities following their interview. The interview was done immediately following their medical checkup and the sequences of the interview was based on their medical checkup. A semi structured questionnaire prepared in English and translated to Amharic language from June to August 2017 was employed. Frequency, cross tabulation, Logistic regression applied to calculate percentage, 95% CI and Odds Ratio with SPSS version 20.0 after cleaned and edited.
Result: In this study a total of 404 female breast cancer cases were assessed of which the mean and SD, age of the study participants was 43.5+7.8 years respectively. Of all study participants 322 (79.7 %) were have comorbidities. Fatty liver 48(11.9%), Neutropenia 43 (10.6%), Gastritis/PUD 34 (8.4%), Anemia 31 (7.7%) were top listed or more prevalent comorbidities in the first and second follow up times. Participants who were not under radiation treatment were 0.37 times less odds to develop comorbidity than under those who were under radiation treatment, OR 0.37, 95% CI (0.19-0.72) and those who did not get hormone treatment were 0.26 times less chance than those who got hormone treatment, OR 0.26, 95% CI (0.16-0.74).
Conclusion and Recommendation: Large number of breast cancer patients had comorbidities. Attention should be given during patient’s diagnosis not to distract breast cancer and comorbidity one with the other, develop system to identify number of comorbidities which used to use the data for action and, Neutropenia, Fatty liver, Gastritis, Anemia were with the highest prevalent comorbidities especially during the first and second follow up of the breast cancer patients so attention shall be given how to management of them.
Description
Keywords
Breast cancer,vulnerability